Efficacy of Deucravacitinib over time in Psoriasis by Baseline Total Body Surface Area: Post Hoc Analysis of the Randomized, Double-blind, Placebo-controlled Phase 3b/4 PSORIATYK SCALP Trial. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 2, p. s537, 2025. DOI: 10.25251/skin.10.supp.537. Disponível em: https://skin.dermsquared.com/skin/article/view/3314. Acesso em: 22 may. 2025.